ETFs Pfizer, Inc.

PFE

US7170811035

Name	Weight	AuM	1st Jan change
AGF U.S. MARKET NEUTRAL ANTI-BETA FUND - USD	14.74%	378 M€	+1.89%	-
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	9.37%	21 M€	+0.03%	-
WEALTHTRUST DBS LONG TERM GROWTH ETF - USD	2.99%	43 M€	+5.15%	-
FRANKLIN U.S. LOW VOLATILITY HIGH DIVIDEND INDEX ETF - USD	2.45%	507 M€	+3.52%	-
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	2.13%	3 M€	-4.30%	-
HANETF SATURNA SUSTAINABLE ESG EQUITY HANZERO UCITS ETF - USD	1.68%	0 M€	-.--%	-
BMO PREMIUM YIELD ETF - CAD	1.5%	263 M€	-6.27%	-
BMO PREMIUM YIELD ETF - USD	1.5%	31 M€	-0.60%	-
BMO PREMIUM YIELD ETF - CAD HEDGED	1.5%	25 M€	-1.84%	-
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD	1.48%	6 M€	0.00%	-
FLEXSHARES DEVELOPED MARKETS HIGH DIVIDEND CLIMATE ESG UCITS ETF - USD	1.46%	0 M€	-.--%	-
HARTFORD MULTIFACTOR US EQUITY ETF - USD	1.07%	418 M€	+2.44%	-
VICTORYSHARES US EQ INCOME ENHANCED VOLATILITY WTD ETF - USD	1.04%	722 M€	+1.04%	-
NEXT FUNDS S&P 500 ESG INDEX EXCHANGE TRADED FUND - JPY	1%	24 M€	-11.03%	-
LEVERAGE SHARES PLC - LS ARK GENOMIC REVOLUTION TRACKER ETP	0.98%	1 M€	-8.93%	-
AGILITY SHARES MANAGED RISK ETF - USD	0.89%	192 M€	-1.12%	-

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.

Employees

81,000

Sector

Pharmaceuticals

Calendar

Aug. 04 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG MSCI

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

24.54USD

Average target price

29.24USD

Spread / Average Target

+19.15%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nyse Other stock markets 04:00:02 2025-06-13 pm EDT			5-day change	1st Jan Change
24.54 ^USD	-1.21%		+5.10%	-7.50%

Jun. 13	Moderna falls on doubts over new CDC panel's backing of RSV vaccine	RE
Jun. 13	Moderna falls on doubts over new CDC panel's backing of RSV vaccine	RE